Structural and biological diversity of lipopolysaccharides from Burkholderia pseudomallei and Burkholderia thailandensis

Clinical and Vaccine Immunology

Volumn 16, Issue 10, 2009, Pages 1420-1428

  Novem, Vidhya ^a   Shui, Guanghou ^b   Wang, Dongling ^a   Bendt, Anne K ^b   Siew, Hoon Sim ^a   Liu, Yichun ^a   Tuck, Weng Thong ^a   Sivalingam, Suppiah Paramalingam ^a   Eng, Eong Ooi ^a,d   Wenk, Markus R ^b,c   Tan, Gladys ^a  

^a DSO NATIONAL LABORATORIES   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c Department of Biological Sciences ^*  (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; INTERLEUKIN 10; INTERLEUKIN 6; LIPID A; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIODIVERSITY; BIOLOGICAL ACTIVITY; BURKHOLDERIA; BURKHOLDERIA PSEUDOMALLEI; BURKHOLDERIA THAILANDENSIS; ELECTROSPRAY MASS SPECTROMETRY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BURKHOLDERIA; BURKHOLDERIA PSEUDOMALLEI; CELL LINE; CYTOKINES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; IMMUNITY, INNATE; LIPID A; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MOLECULAR STRUCTURE; SPECIES SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TOLL-LIKE RECEPTOR 4; VIRULENCE;

EID: 70349695688     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00472-08     Document Type: Article

References (61)

1. Arjcharoen, S., C. Wikraiphat, M. Pudla, K. Limposuwan, D. E. Woods, S. Sirisinha, and P. Utaisincharoen. 2007. Fate of a Burkholderia pseudomallei lipopolysaccharide mutant in the mouse macrophage cell line RAW 264.7: possible role for the O-antigenic polysaccharide moiety of lipopolysaccharide in internalization and intracellular survival. Infect. Immun. 75:4298-4304.
2. Bäckhed, F., S. Normark, E. K. Schweda, S. Oscarson, and A. Richter-Dahlfors. 2003. Structural requirements for TLR4-mediated LPS signalling: a biological role for LPS modifications. Microbes Infect. 5:1057-1063. (Pubitemid 37211466)
3. Bosshart, H., and M. Heinzelmann. 2007. Targeting bacterial endotoxin: two sides of a coin. Ann. N. Y. Acad. Sci. 1096:1-17.
4. Braedel-Ruoff, S., M. Faigle, N. Hilf, B. Neumeister, and H. Schild. 2005. Legionella pneumophila mediated activation of dendritic cells involves CD14 and TLR2. J. Endotoxin Res. 11:89-96.
5. Brett, P. J., M. N. Burtnick, D. S. Snyder, J. G. Shannon, P. Azadi, and F. C. Gherardini. 2007. Burkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes. Mol. Microbiol. 63:379-390.
6. Caroff, M., and D. Karibian. 2003. Structure of bacterial lipopolysaccharides. Carbohydr. Res. 338:2431-2447.
7. Chaowagul, W., N. J. White, D. A. Dance, Y. Wattanagoon, P. Naigowit, T. M. Davis, S. Looareesuwan, and N. Pitakwatchara. 1989. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J. Infect. Dis. 159:890-899.
8. Charuchaimontri, C., Y. Suputtamongkol, C. Nilakul, W. Chaowagul, P. Chetchotisakd, N. Lertpatanasuwun, S. Intaranongpai, P. J. Brett, and D. E. Woods. 1999. Antilipopolysaccharide II: an antibody protective against fatal melioidosis. Clin. Infect. Dis. 29:813-818.
9. Cheng, A. C., and B. J. Currie. 2005. Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 18:383-416.
10. Christenson, B., Z. Fuxench, J. A. Morales, R. A. Suarez-Villamil, and L. M. Souchet. 2003. Severe community-acquired pneumonia and sepsis caused by Burkholderia pseudomallei associated with flooding in Puerto Rico. Bol. Asoc. Med. P. R. 95:17-20.
11. Dance, D. A. 2000. Ecology of Burkholderia pseudomallei and the interactions between environmental Burkholderia spp. and human-animal hosts. Acta Trop. 74:159-168.
12. Dance, D. A. 1991. Melioidosis: the tip of the iceberg? Clin. Microbiol. Rev. 4:52-60.
13. Dharakul, T., and S. Songsivilai. 1999. The many facets of melioidosis. Trends Microbiol. 7:138-140.
14. Ernst, R. K., S. M. Moskowitz, J. C. Emerson, G. M. Kraig, K. N. Adams, M. D. Harvey, B. Ramsey, D. P. Speert, J. L. Burns, and S. I. Miller. 2007. Unique lipid A modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis. J. Infect. Dis. 196:1088-1092.
15. Gibbons, H. S., S. Lin, R. J. Cotter, and C. R. Raetz. 2000. Oxygen requirement for the biosynthesis of the S-2-hydroxymyristate moiety in Salmonella typhimurium lipid A. Function of LpxO, a new Fe2+/alpha- ketoglutarate-dependent dioxygenase homologue. J. Biol. Chem. 275:32940-32949.
16. Glass, M. B., J. E. Gee, A. G. Steigerwalt, D. Cavuoti, T. Barton, R. D. Hardy, D. Godoy, B. G. Spratt, T. A. Clark, and P. P. Wilkins. 2006. Pneumonia and septicemia caused by Burkholderia thailandensis in the United States. J. Clin. Microbiol. 44:4601-4604.
17. Gunn, J. S. 2001. Bacterial modification of LPS and resistance to antimicrobial peptides. J. Endotoxin Res. 7:57-62. (Pubitemid 32496461)
18. Guo, L., K. B. Lim, J. S. Gunn, B. Bainbridge, R. P. Darveau, M. Hackett, and S. I. Miller. 1997. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 276:250-253.
19. Hirschfeld, M., Y. Ma, J. H. Weis, S. N. Vogel, and J. J. Weis. 2000. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J. Immunol. 165:618-622. (Pubitemid 30484724)
20. Hirschfeld, M., J. J. Weis, V. Toshchakov, C. A. Salkowski, M. J. Cody, D. C. Ward, N. Qureshi, S. M. Michalek, and S. N. Vogel. 2001. Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 69:1477-1482.
21. Ho, M., T. Schollaardt, M. D. Smith, M. B. Perry, P. J. Brett, W. Chaowagul, and L. E. Bryan. 1997. Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies. Infect. Immun. 65:3648-3653.
22. Inglis, T. J., M. Aravena-Roman, S. Ching, K. Croft, V. Wuthiekanun, and B. J. Mee. 2003. Cellular fatty acid profile distinguishes Burkholderia pseudomallei from avirulent Burkholderia thailandensis. J. Clin. Microbiol. 41:4812-4814.
23. Inglis, T. J., D. B. Rolim, and Q. Sousa Ade. 2006. Melioidosis in the Americas. Am. J. Trop. Med. Hyg. 75:947-954.
24. Jones, A. L., T. J. Beveridge, and D. E. Woods. 1996. Intracellular survival of Burkholderia pseudomallei. Infect. Immun. 64:782-790.
25. Kawasaki, K., R. K. Ernst, and S. I. Miller. 2005. Inhibition of Salmonella enterica serovar Typhimurium lipopolysaccharide deacylation by aminoarabinose membrane modification. J. Bacteriol. 187:2448-2457.
26. Lee, H. K., J. Lee, and P. S. Tobias. 2002. Two lipoproteins extracted from Escherichia coli K-12 LCD25 lipopolysaccharide are the major components responsible for Toll-like receptor 2-mediated signaling. J. Immunol. 168:4012-4017.
27. Leelarasamee, A. 2004. Recent development in melioidosis. Curr. Opin. Infect. Dis. 17:131-136.
28. Leelarasamee, A., and S. Bovornkitti. 1989. Melioidosis: review and update. Rev. Infect. Dis. 11:413-425.
29. Leon, C. G., R. Tory, J. Jia, O. Sivak, and K. M. Wasan. 2008. Discovery and development of toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases. Pharm. Res. 25:1751-1761.
30. Liu, Y., J. P. Loh, L. T. Aw, E. P. Yap, M. A. Lee, and E. E. Ooi. 2006. Rapid molecular typing of Burkholderia pseudomallei, isolated in an outbreak of melioidosis in Singapore in 2004, based on variable-number tandem repeats. Trans. R. Soc. Trop. Med. Hyg. 100:687-692.
31. Matsuura, M., K. Kawahara, T. Ezaki, and M. Nakano. 1996. Biological activities of lipopolysaccharide of Burkholderia (Pseudomonas) pseudomallei. FEMS Microbiol. Lett. 137:79-83.
32. Miller, S. I., R. K. Ernst, and M. W. Bader. 2005. LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 3:36-46.
33. Ministry of Health Singapore. 2006. Communicable diseases surveillance in Singapore 2006, p. 80-89. Ministry of Health Singapore, Singapore.
34. Ministry of Health Singapore. 2004. Epidemiological investigations into an epidemic of melioidosis, January-June 2004. Epidemiol. News Bull. 30:24-28.
35. Molinaro, A., B. Lindner, C. De Castro, B. Nolting, A. Silipo, R. Lanzetta, M. Parrilli, and O. Holst. 2003. The structure of lipid A of the lipopolysaccharide from Burkholderia caryophylli with a 4-amino-4-deoxy-L- arabinopyranose 1-phosphate residue exclusively in glycosidic linkage. Chemistry 9:1542-1548.
36. Montminy, S. W., N. Khan, S. McGrath, M. J. Walkowicz, F. Sharp, J. E. Conlon, K. Fukase, S. Kusumoto, C. Sweet, K. Miyake, S. Akira, R. J. Cotter, J. D. Goguen, and E. Lien. 2006. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat. Immunol. 7:1066-1073.
37. Nelson, D. L., and E. P. Kennedy. 1971. Magnesium transport in Escherichia coli. Inhibition by cobaltous ion. J. Biol. Chem. 246:3042-3049.
38. Nelson, M., J. L. Prior, M. S. Lever, H. E. Jones, T. P. Atkins, and R. W. Titball. 2004. Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis. J. Med. Microbiol. 53:1177-1182.
39. Perry, M. B., L. L. MacLean, T. Schollaardt, L. E. Bryan, and M. Ho. 1995. Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei. Infect. Immun. 63:3348-3352.
40. Phillips, N. J., B. Schilling, M. K. McLendon, M. A. Apicella, and B. W. Gibson. 2004. Novel modification of lipid A of Francisella tularensis. Infect. Immun. 72:5340-5348.
41. Raetz, C. R., and C. Whitfield. 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71:635-700.
42. Rietschel, E. T., T. Kirikae, F. U. Schade, U. Mamat, G. Schmidt, H. Loppnow, A. J. Ulmer, U. Zahringer, U. Seydel, F. Di Padova, et al. 1994. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8:217-225.
43. Rolim, D. B., D. C. Vilar, A. Q. Sousa, I. S. Miralles, D. C. de Oliveira, G. Harnett, L. O'Reilly, K. Howard, I. Sampson, and T. J. Inglis. 2005. Melioidosis, northeastern Brazil. Emerg. Infect. Dis. 11:1458-1460.
44. Seydel, U., A. B. Schromm, R. Blunck, and K. Brandenburg. 2000. Chemical structure, molecular conformation, and bioactivity of endotoxins. Chem. Immunol. 74:5-24.
45. Shui, G., A. K. Bendt, K. Pethe, T. Dick, and M. R. Wenk. 2007. Sensitive profiling of chemically diverse bioactive lipids. J. Lipid Res. 48:1976-1984. (Pubitemid 47360617)
46. Silipo, A., A. Molinaro, P. Cescutti, E. Bedini, R. Rizzo, M. Parrilli, and R. Lanzetta. 2005. Complete structural characterization of the lipid A fraction of a clinical strain of B. cepacia genomovar I lipopolysaccharide. Glycobiology 15:561-570.
47. Smith, M. D., B. J. Angus, V. Wuthiekanun, and N. J. White. 1997. Arabinose assimilation defines a nonvirulent biotype of Burkholderia pseudomallei. Infect. Immun. 65:4319-4321.
48. Somerville, J. E., Jr., L. Cassiano, B. Bainbridge, M. D. Cunningham, and R. P. Darveau. 1996. A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. J. Clin. Investig. 97:359-365.
49. Tirsoaga, A., A. Novikov, M. Adib-Conquy, C. Werts, C. Fitting, J. M. Cavaillon, and M. Caroff. 2007. Simple method for repurification of endotoxins for biological use. Appl. Environ. Microbiol. 73:1803-1808.
50. Trent, M. S. 2004. Biosynthesis, transport, and modification of lipid A. Biochem. Cell Biol. 82:71-86.
51. Utaisincharoen, P., N. Tangthawornchaikul, W. Kespichayawattana, N. Anuntagool, P. Chaisuriya, and S. Sirisinha. 2000. Kinetic studies of the production of nitric oxide (NO) and tumour necrosis factor-alpha (TNF-alpha) in macrophages stimulated with Burkholderia pseudomallei endotoxin. Clin. Exp. Immunol. 122:324-329.
52. Utaisincharoen, P., N. Tangthawornchaikul, W. Kespichayawattana, P. Chaisuriya, and S. Sirisinha. 2001. Burkholderia pseudomallei interferes with inducible nitric oxide synthase (iNOS) production: a possible mechanism of evading macrophage killing. Microbiol. Immunol. 45:307-313.
53. West, T. E., R. K. Ernst, M. J. Jansson-Hutson, and S. J. Skerrett. 2008. Activation of Toll-like receptors by Burkholderia pseudomallei. BMC Immunol. 9:46.
54. Wiersinga, W. J., and T. van der Poll. 2009. Immunity to Burkholderia pseudomallei. Curr. Opin. Infect. Dis. 22:102-108.
55. Wiersinga, W. J., C. W. Wieland, M. C. Dessing, N. Chantratita, A. C. Cheng, D. Limmathurotsakul, W. Chierakul, M. Leendertse, S. Florquin, A. F. de Vos, N. White, A. M. Dondorp, N. P. Day, S. J. Peacock, and T. van der Poll. 2007. Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (melioidosis). PLoS Med. 4:e248.
56. Wilson, J. W., M. J. Schurr, C. L. LeBlanc, R. Ramamurthy, K. L. Buchanan, and C. A. Nickerson. 2002. Mechanisms of bacterial pathogenicity. Postgrad. Med. J. 78:216-224.
57. Woods, D. E., D. DeShazer, R. A. Moore, P. J. Brett, M. N. Burtnick, S. L. Reckseidler, and M. D. Senkiw. 1999. Current studies on the pathogenesis of melioidosis. Microbes Infect. 1:157-162.
58. Yi, E. C., and M. Hackett. 2000. Rapid isolation method for lipopolysaccharide and lipid A from gram-negative bacteria. Analyst 125:651-656.
59. Zhou, Z., A. A. Ribeiro, S. Lin, R. J. Cotter, S. I. Miller, and C. R. Raetz. 2001. Lipid A modifications in polymyxin-resistant Salmonella typhimurium: PMRA-dependent 4-amino-4-deoxy-L-arabinose, and phosphoethanolamine incorporation. J. Biol. Chem. 276:43111-43121.
60. Zughaier, S. M., H. C. Ryley, and S. K. Jackson. 1999. Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes. Infect. Immun. 67:1505-1507.
61. Zughaier, S. M., S. M. Zimmer, A. Datta, R. W. Carlson, and D. S. Stephens. 2005. Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect. Immun. 73:2940-2950.